A Seattle-based venture capital firm has raised more than a quarter of $1 billion for its second fund and added two executives, one of whom comes from the world’s largest philanthropic organization.

Seattle-based venture capital firm Biomatics Capital, which focuses on companies innovating around healthcare and technology, has closed its initiatory fund of $200 million. This exceeds the firm’s ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--eGenesis, a biotechnology company focused on utilizing genome editing technology to make xenotransplantation a routine and lifesaving medical procedure, today ...

Dr. Boris Nikolic, science advisor to none other than Bill Gates, is launching a new life sciences fund. Seattle-based Biomatics Capital Partners is looking to raise $150 million, according to a ...

Seattle-based Biomatics Capital Partners closed its initiatory fund of $200 million. The venture capital firm intends to focus on investing in genomics, digital health and data-driven healthcare ...

Biomatics Capital Partners has raised $300 million for its second fund and signed on two new venture partners: serial biotech entrepreneur Errik Anderson and Mike Poole, M.D., most recently of the ...

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Biomatics Capital Partners, a fledgling venture capital (VC) firm based ...

SEATTLE, March 15, 2017 /PRNewswire/ -- Biomatics Capital Partners, a venture capital firm investing in transformational innovation at the intersection of health care and technology, has announced the ...

He’s helped found at least seven biotech companies. This year he co-founded the New England Free Jacks, Boston’s first professional rugby team. Now Errik Anderson, a 40-year-old Hanover, N.H., ...

SEATTLE, Nov. 8, 2018 /PRNewswire/ -- Biomatics Capital Partners, a venture capital firm focused on advancing data-enabled healthcare innovations, has launched its second fund — raising $300 million ...